Study: Children, Parents Over-Report Leukemia Treatment Adherence
Feb 02, 2017
New research suggests that young patients with acute lymphocytic leukemia (ALL) — the most common type of pediatric cancer — and their and their parents are likely to report to their physician that they took more of their anti-cancer medication than they actually did.
Statement from ASH, AACR, AACI, ASTRO, ASPHO, and LUNGevity Foundation on the Administration’s Executive Order on Immigration
Feb 01, 2017
As the world's leading organizations representing laboratory researchers, physician-scientists, clinicians, the nation’s cancer centers, and patient advocates committed to improved care for patients with cancer and blood diseases, we express our deep concern about the Administration’s executive order that has denied U.S. entry to people who bring unique expertise to the practice of medicine and the conduct of cancer and biomedical research.
ASH President Submits Letter to Secretary-Designate Tom Price on 2017 Health Care and Research Priorities
Jan 26, 2017
ASH President Kenneth C. Anderson, MD, has submitted the Society’s 2017 policy priorities to Secretary Designee of the United States Department of Health and Human Services Tom Price, MD. The letter affirms the Society’s commitment to working with policymakers on the following issues important to hematology.